Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03585660 · ClinicalTrials.gov registry record · NA

Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy

A NA study of Prostate Cancer, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
106
Enrollment target
1
Study location

NCT03585660 is a NA study of Prostate Cancer that has completed, run by University of Chicago. The registered enrollment target is 106 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03585660, a NA study of Prostate Cancer, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
106 participants
Enrollment target
1
Study location

Study Summary

The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE Diagnostic MRI
  • PROCEDURE Diagnostic Prostate Biopsy
  • DEVICE Risk Map DSS tool

Study Locations (1)

Illinois

  • University of Chicago Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 106 participants
Start Date 2018-08-28
Est. Completion 2023-11-06
Phase NA

Sponsor

University of Chicago

796 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03585660

The ClinicalTrials.gov registry entry for NCT03585660 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 106 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (83% lower). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 3 interventions - of which Diagnostic MRI is the first listed.

NCT03585660 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT03585660 about?

NCT03585660 is a clinical study titled "Developing an Imaging-Based Tool to Identify Areas for Prostate Cancer Biopsy". The purpose of the proposed research is to test and validate a Risk Map decision-support system (DSS) for prostate cancer Magnetic Resonance Imaging (MRI) interpretation and identification of clinically significant tumor site(s).

What is the current status of trial NCT03585660?

This trial is currently completed. It is a NA study. The enrollment target is 106 participants. The study started on 2018-08-28. Estimated completion is 2023-11-06.

What conditions does trial NCT03585660 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT03585660?

The interventions under investigation include: Diagnostic MRI (PROCEDURE), Diagnostic Prostate Biopsy (PROCEDURE), Risk Map DSS tool (DEVICE).

Who is sponsoring clinical trial NCT03585660?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03585660 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.